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To investigate susceptibility to and factors associated with rubella infection among pregnant mothers and 
to estimate the burden of congenital rubella infection (CRI) in Vietnam where rubella-containing vaccine 
(RCV) is not included in the routine immunization programme, we conducted a prospective cohort study 
in Nha Trang, Vietnam between 2009 and 2010. Rubella-specific immunoglobulin-M and 
immunoglobulin-G were investigated in cord blood samples by enzyme immunoassay. Corresponding 
clinical-epidemiological data were analyzed and the national congenital rubella syndrome (CRS) 
incidence was estimated using modeling. We enrolled 1988 pairs of mothers aged 17-45 years and their 
newborn babies. No mothers had received RCV. Multivariate analysis revealed that mothers aged 17-24 
(aOR 2.5, 95% CI: 1.7-3.8) or 25-34 (1.4, 1.0-2.1) years were more likely to be susceptible than those 
aged 35-45 years. Overall 28.9% (574/1988, 95% CI: 26.9-30.9%)  of mothers were seronegative. The 
CRI rate was 151 (95% CI: 0-322) per 100,000 live births. Modeling estimated that 3788 babies (95% CI: 
3283-4143) were born with CRS annually in Vietnam with an overall CRS incidence of 234 (95% CI: 
207-262) cases per 100,000 live births. A substantial proportion of women of childbearing age (WCBA) 
are at risk of rubella infection during pregnancy and this can result in a high frequency of miscarriage or 
burden of CRS across Vietnam. Prompt introduction of RCV into national immunization programme with 
catch-up vaccination to children and WCBA will reduce CRI in Vietnam. 
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Rubella is a mild self-limiting infection associated with fever and rash and mainly occurring in 
children. However, if infected in their first 8-10 weeks of gestation, up to 90% of pregnant women may 
face miscarriage, stillbirth or a child born with congenital rubella syndrome (CRS).  This is associated 
with significant disability, including sensorineural deafness, cataract, and cardiac defects [1-3]. Therefore 
the primary goal in controlling rubella is to prevent miscarriage and CRS by an adequate rubella 
immunization programme [2]. 
The epidemiology and burden of CRS in Vietnam is poorly understood.  The number of WHO 
member countries which had introduced rubella-containing vaccine (RCV) into their routine immunization 
programme increased from 83 (43%) in 1996 to 131 (68%) in 2010, resulting in an 82% decline in the 
number of reported rubella cases by 2009 [4,5]. However, out of 36 countries in the Western Pacific 
Region, Vietnam remains one of 6 countries which have not used RCV as of 2009, and has been 
experiencing periodic rubella outbreaks and, potentially, a large burden of CRS. Adolescents and adults 
comprised most of the reported cases of rubella in outbreaks, and, notably, 60% of female cases were 
WCBA in 2009 [6,7]. 
Due to under-reporting of rubella cases and difficulties with diagnosing CRS, estimates of the 
incidence of rubella and burden of CRS obtained from surveillance data are often unreliable. However, 
adequate population-based serological data collected through a prospective cohort study may provide 
insight into these statistics. Such data have not been available in Vietnam before 2012. 
In this paper, we describe a prospective cohort study of rubella serological survey in Nha Trang, 
Central Vietnam which aimed to 1) investigate susceptibility to and factors associated with rubella 
infection among pregnant mothers, 2) investigate the rate and outcomes of congenital rubella infection 




2 Materials and Methods 
2.1.   Study Design, Period and Location 
A prospective cohort study was conducted from May 2009 through May 2010 in Nha Trang. This 
study site has a population of approximately 390,000 and is located in Khanh Hoa Province, Central 
Vietnam. Khanh Hoa General Hospital (KHGH) is a provincial hospital with 900 beds which covers the 
whole Khanh Hoa Province, and provides comprehensive medical services, with approximately 6000 
babies delivered annually. The study was conducted in 16 out of 24 communes in Nha Trang because 
detailed population and demographic data were available for these communes from our census surveys in 
2006 and 2010. Since Nha Trang is a tourist city, communes which have big blocks of government 
administrative buildings, hotels and restaurant areas were not included in the survey. RCV has not been 
introduced into the national immunization programme at the time of the study. A negligible proportion of 
the population is believed to get access to RCV at the private sector/clinics in Nha Trang, although private 
sector vaccination services have been expanding in Hanoi and Ho Chi Minh City [7]. 
2.2.   Subjects and Recruitment Process 
The samples were collected as part of a birth cohort study. Mothers aged ≥17 years residing in 16 
target communes in Nha Trang who delivered a single child at KHGH without severe complications on 
weekdays during this study period were recruited, together with their newborn babies. The study 
recruited pregnant women with no serious complications on admission during the study period because it 
is unethical or difficult to ask a pregnant mother who is in a serious condition on admission for informed 
consent. We did not recruit women who give birth to two or more babies in the study because the CRI 
rate of the babies may differ and it will be difficult to analyze the risk factors. We did not collect samples 
during weekends due to a shortage of staff, but recorded all the deliveries, including those on weekends, 
to calculate the CRI incidence. Written informed consent was obtained from participants, and clinical-
epidemiological information was collected through interview using a structured questionnaire before the 
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delivery and from medical charts or maternal health cards. The whole process was done by two trained 
research nurses and supervised by a research clinician. 
2.3.  Sample Collection and Testing 
Cord blood samples were collected at the time of delivery. The blood was centrifuged for 5 minutes at 
1500 rpm, and separated plasma was kept in -80°C freezers. The plasma samples were transported to 
Nagasaki, Japan [8], and tested for rubella-specific Immunoglobulin-M (IgM) and Immunoglobulin-G 
(IgG) by enzyme immunoassay (EIA) (Mini VIDAS). The cut-off values of the assay were 1.2 and 4.0, 
respectively, in accordance with the company recommendation. 
2.4.   Characteristic Categorization Definition 
Maternal educational level was categorized into three groups, based on the educational system in 
Vietnam, namely none-primary, lower-upper secondary and higher education, which were defined as 0-5, 
6-12, and ≥13 years of schooling, respectively [9]. Paternal occupations were classified into four groups: 1, 
unemployed (including students); 2, unskilled workers/farmers/soldiers; 3, officers/skilled workers; and 4, 
professionals/owners of enterprise. Residential areas where the mothers lived were defined as urban and 
rural according to Vietnam government administrative categorization. The number of mothers who visited 
antenatal care (ANC) ≥4 times was calculated, following WHO recommendations [10]. Body mass index 
(BMI) was defined as the weight in kilograms divided by the square of the height in meters (kg/m2) and 
underweight was classified as BMI <18.5 by WHO criteria [11]. Anemia was defined for pregnant women 
according to WHO criteria as a haemoglobin of <11.0 g/dl [12].  Births were considered preterm if they 
occurred after less than 37 gestational weeks (GWs), and low birth weight (LBW) if the birth weight 
(BW) was less than 2500 g, following the guidelines in the International Classification of Diseases-10: 
version 2010 [13]. A diagram of BW percentiles by GWs was created based on data collected from 
subjects, using previous methods [14,15], with a mean BW at 40 weeks of 3379.6 g and a standard 
deviation of 11.4% of the mean BW. Babies who were “light-for-dates” (defined as those with BW below 
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the 10th percentile [13]) were identified from this figure (Appendix 1). CRI was defined using the WHO 
case definition [15] as infection with no clinical signs of CRS but positive for rubella-specific IgM. 
2.5.   Data Management, Statistical Analysis 
All the collected information was managed confidentially throughout the process. The data were 
double-entered and cleaned, and statistical analysis was conducted with IBM SPSS Statistics 18. Odds 
ratio (OR) or adjusted OR (aOR) with its 95% confidence interval (95% CI) and p-values for factors 
associated with seronegativity were calculated by either chi-square or logistic regression for univariate 
analysis and by logistic regression for multivariate analyses. A p-value of less than 0.05 was considered 
statistically significant. The overall proportion of individuals who were seronegative based on rubella-
specific IgG and the proportion who were rubella-specific IgM-positive were calculated together with 
their 95% CI. The age distribution of the enrolled mothers and the age-specific proportion that were 
seronegative were plotted. Infants with CRI were invited for medical follow-up including physical, 
neurodevelopment and auditory examinations at 10 months and 24 months of age. Auditory function tests 
were conducted with distortion product otoacoustic emission for the former session and automated 
auditory brainstem response for the latter (echo-screen II). Furthermore, cardiovascular examination was 
conducted with echocardiogram (Viamo SSA-640A) for the latter session. Japanese pediatricians 
performed the above examinations in cooperation with Vietnamese staff. 
2.6.   Estimating the CRS Incidence using Modeling 
Following previous methods [16], an age-structured catalytic model was fitted to the observed age-
stratified serological data using maximum likelihood to estimate the force of infection for rubella (defined 
as the rate at which susceptible are infected per unit time).  The force of infection was assumed to differ 
between the age groups <13 years and ≥13 years.  The best-fitting value for the force of infection was then 
used to estimate the CRS incidence per 100,000 live births among women in 5 year age groups, aged 
between 15 and 44 years using the equation 0.65×s(A)(1- exp(-16λo/52) )×100,000, where s(A) is the 
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proportion of women in age group A that are susceptible and λo is the force of infection among those 
aged over 13 years.  The CRS incidence per 100,000 live births among mothers aged 15-44 was calculated 
as the average of the CRS incidence per 100,000 live births in each five-year maternal age group, 
weighted by the number of live births in the corresponding maternal age group in 2009. 
As in previous analyses [16], the risk that a child was born with CRS was assumed to be 65% if the 
mother was infected during the first 16 weeks of pregnancy and zero thereafter. The CRS incidence per 
live birth among women in each age group was then multiplied by estimates of the number of live births 
(including those occurring at week-ends) occurring among women in the corresponding age group in 2009, 
in these areas to obtain the number of CRS cases born in the five-year age group.  The number of live 
births was calculated by multiplying the age-specific fertility rates [17] by the age-specific number of 
females in each age group in 2009, as estimated in the national census conducted in the year 2010 [18]. 
Confidence intervals on the force of infection and CRS incidence were obtained by profile likelihood. 
2.7.   Ethical Consideration 
This study was approved by the Ethical Committees of Nagasaki University (Japan) and National 




During the study period, 3173 deliveries by mothers living in 16 target communes in Nha Trang were 
reported in total. Of them, 2787 (87.8%) occurred at KHGH and 1988 (62.7%) mothers who fitted the 
recruitment criteria were enrolled for this study. 
Characteristics of the enrolled participants 
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The mean age of the enrolled mothers was 27.9 years, ranging from 17 to 45 years with the ages following 
normal distribution (Figure 1). Over 85% of mothers had received lower secondary or higher education, 
and nearly all fathers had some occupation. Seventy percent of mothers were urban residents. About 50% 
of mothers were primiparous, and nearly 85% had visited antenatal clinics at least 4 times for this 
pregnancy. Over a quarter of mothers had a low BMI and around a quarter were anemic. As many as 
41.8% of all births were delivered by caesarean section regardless of the underlying reason. Mean GWs at 
deliveries were 39.1 weeks with 3.4% being preterm. The male-to-female ratio was 51.6 : 48.4. Their 
mean BW was 3262.7 g with 2.3% LBW and 10.9% “light-for-date” (Table 1). None of the mothers had 
been vaccinated with RCV. 
Factors Associated with Seronegativity 
Overall, 28.9% (574/1988 [95% CI: 26.9-30.9%]) of mothers were seronegative with an increased 
proportion (44.3% [95% CI: 34.3-54.4%]) of mothers aged 17-19 years being seronegative (Table 2). 
Young age, primipara, increased number of ANC visits, and preterm delivery were significantly 
associated with maternal seronegativity in univariate analyses, while in multivariate analyses the only 
significant factors were young age (aOR2.5 [95% CI: 1.7-3.8] and 1.4 [95% CI: 1.0-2.1] for 17-24 and 25-
34 year olds, respectively, compared to those aged 35-45 years), and increased number of ANC visits 
(aOR1.7 [95% CI: 1.2-2.3] for those with ≥4 ANC visits, compared with those with <4 visits) (Table 1) 
Rubella-specific IgM-positive participants 
Three infants were positive for rubella-specific IgM among 1988 study subjects; therefore, the CRI rate in 
this study was 151 (95% CI: 0-322) per 100,000 live births. Their mothers lived in different residential 
areas, and no rubella epidemic had been reported in those areas during the study period. None of them had 
apparent abnormalities in physical examinations at birth. Two of them were evaluated at 10 months and 24 
months of age and showed no abnormalities in physical examinations, neurodevelopmental tests, 
echocardiography, and auditory function tests. The parent of the remaining child reported in a telephone 
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interview that he had been well without any apparent delay in psychomotor or language development, 
although we could not examine him because his family had moved outside the study area.  
Model-based estimates of the CRS Incidence 
The best-fitting value for the force of infection was about 5.3%/year (95% CI: 4.7-5.8%) for children aged 
<13 years and about 3.9%/year (95% CI: 3.5-4.4%/year) for those aged ≥13 years (log likelihood 
deviance: 28, 21df) (Figure 2).  The estimated CRS incidence was about 234 per 100,000 live births 
among 15-44 year olds, and decreased with increasing age from 348 per 100,000 births among women 
aged 15-19 years to 130 per 100,000 live births among those aged 40-44 years (Table 2). 
After combining these figures with data on the number of live births, these estimates suggest that 
3788 babies (95% CI: 3283-4143) were born with CRS in Vietnam in 2009, with 24 (95% CI: 21-26), 36 




This study is the first population-based large-scale seroprevalence study among pregnant women in 
Vietnam elucidating the risk of rubella infection for WCBA in this country. Overall, a very high 
proportion (28.9%) of WCBA were found to be susceptible, suggesting that the incidence of CRS per 
100,000 live births was also very high (234 per 100,000 live births) with over 3000 cases of CRS born 
each year.   
The only previous data relating to rubella seroprevalence in Vietnam considered pregnant Vietnamese 
emigrants in Taiwan and Australia [19, 20]. Our finding that 28.9% of pregnant women were susceptible 
to rubella is consistent with that from these reports, in which 24-36% of pregnant women were susceptible 
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[19, 21]. In another study investigating 45 developing countries before RCV had been used, the 
susceptibility in WCBA was generally 15-20% but exceeded 25% in 12 countries [22].5,5 
 
Multivariate analysis revealed that young maternal age was associated with seronegativity. After 
multivariate analysis including all other possible confounding factors in the model aside from age, aOR 
for age still remained over 1.0, which indicates that it can be an independent factor for increased risk of 
rubella infection. 
Our multivariate analysis supported no association of parity or maternal educational status with 
rubella susceptibility, which is consistent with findings elsewhere [23-26]. Apparent association on 
univariate analysis was probably due to increased maternal age as a confounding factor, although there 
might be a potential risk of transmission from elder siblings to mothers. 
Association of residential area, e.g. rural or urban, with seropositivity has also varied between studies.  
For example, some studies conducted before rubella vaccination was introduced found lower levels of 
seropositivity in rural than in urban areas [27], one recent study found the converse [25], while no 
association was identified elsewhere [23,26] as seen from this study. Rubella-specific IgM tests identified 
three infants with CRI, which implies a CRI rate of 151 (95% CI: 0-322) per 100,000 live births. This low 
incidence rate  is consistent with the fact that no epidemic had been reported during the study period. 
None of these babies had apparent abnormalities, confirming that there are more individuals with CRI 
than with clinically apparent CRS. 
We estimated that on average 3788 (95% CI: 3283-4143) infants with CRS would be born annually 
in Vietnam with 234 (95% CI: 207-262) cases per 100,000 live births.  This estimate is not significantly 
different from that in a study at the National Obstetric Hospital, Hanoi, where the incidence of CRS was 
210 per 100,000 live births [28]. Differences between the model predictions and the reported number of 
CRS cases may be attributed to several factors, including under-reporting, resulting from problems with 
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diagnosing CRS in infants, and the fact that the estimate does not account for abortions which may have 
occurred once pregnant mothers became infected. 
This study has several limitations. First of all, this study only considered seroprevalence in Nha 
Trang, located in central Vietnam.  This area is perhaps more rural than other parts of Vietnam and the 
findings may not be easily generalizable to other areas. However, since our study covered the majority of 
deliveries in this area, our results are probably generalizable to similar regions in Vietnam. Second, we 
could have introduced selection bias by restricting recruitment to women who lived in 16 out of 24 
communes in Nha Trang and delivered on weekdays. But excluding the samples on weekends should not 
have any significant effect on the CRS incidence calculated using by modeling, since the calculations used 
the age-specific proportion of women who were seronegative and the total number of deliveries, including 
those occurring on weekends.  Thirdly, the present study considered the seroprevalence in women aged 
17-45 years but had no data from younger ages. Seroprevalence data from all age groups should provide 
improved insight into the epidemiology of rubella and extent of ongoing transmission in Vietnam. Finally, 
following WHO recommendations, we used EIA for rubella-specific IgM when diagnosing CRS cases [8], 
although this has a low positive predictive value in low transmission settings and lower sensitivity, 
compared to the virus genome detection by reverse transcription polymerase chain reaction (RT-PCR).  
However, due to logistical and technical constraints, RT-PCR was not used.  
The high proportion (28.9%) of WCBA that were found to be susceptible and the high burden of 
CRS predicted by modeling suggest that there is a need to introduce immunization with RCV into 
Vietnam. 
Since females aged 17-24 years are at increased risk of giving birth to infants with CRS, adolescent 
girls should be targeted for RCV immunization to prevent CRS, as described previously [29, 30]. To do so, 
as many opportunities as possible would need to be exploited, including supplementary immunization 
activities carried out for measles, visits for children’s immunization, and postpartum check-up, as 
suggested previously [6, 7, 31]. School-based programs for girls, similar to those conducted elsewhere in 
12 
 
the past [29] may be feasible in Vietnam, where 80% of girls attend secondary school [32]. Furthermore, 
since the current national programme to give 3 doses of tetanus toxoid targets to women aged 15-35 years 
in high-risk areas, extension of this programme to other regions will provide further opportunities for 
RCV immunization [7]. 
In addition, coverage of measles vaccination is quite high in Vietnam, providing favorable conditions 
for adding RCV in the Expanded Program of Immunization (EPI) for children. Two doses of measles 
vaccine for children at age 9 and 18 months can be replaced by Measles-Rubella or Measles-Mumps-
Rubella vaccine in the revised EPI, the cost-effectiveness of which has been estimated previously [6]. 
However, as found elsewhere and suggested by modeling [2, 29, 34, 35], introducing RCV into childhood 
EPI at coverage levels which are too low can lead to adverse increases in the proportion of women that are 
susceptible to infection and the incidence of CRS. Therefore, a catch-up campaign targeting all children 
aged 13 years or younger and vaccinating WCBA would need to be introduced RCV is introduced into the 
routine schedule.  
Finally, establishment of CRS surveillance is recommended, so that the actual burden of CRS can be 
directly measured and to help assess the effectiveness of the revised preventive interventions [2, 31]. 
In conclusion, a substantial proportion of WCBA are at risk of rubella infection during pregnancy, 
potentially resulting in a large burden of miscarriage or CRS in Vietnam. Prompt introduction of RCV to 
WCBA is strongly recommended for averting such adverse outcomes. In order to eliminate rubella, this 
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Table 1. Demographic characteristics and factors associated with seronegativity for rubella-specific IgG, 
Nha Trang, Vietnam, 2009-2010 





  N (%) N (%) OR (95% CI) aOR (95% CI) 
【Mothers】 
Maternal Age (in years)b 
    17-24 572 (28.8) 213 (37.2) 2.5a (1.8, 3.7) 2.5 (1.7, 3.8) 
25-34 1166 (58.7) 313 (26.8) 1.6 (1.1, 2.2) 1.4 (1.0, 2.1) 
35-44 249 (12.5) 47 (18.9) Ref Ref 
45 1(0.05) 1 (100) - - 
Maternal Educationb 
    None-Primary 249 (12.5) 58 (23.3) 0.7 (0.5, 1.0) 0.9 (0.6, 1.3) 
Lower-Upper Secondary 1240 (62.4) 367 (29.6) 1.0 (0.8, 1.2) 1.0 (0.8, 1.3) 
Higher 499 (25.1) 149 (29.9) Ref Ref 
Paternal Occupation 
    Unemployed 6 (0.3) 3 (50.0) 2.1 (0.4, 10.5) 1.6 (0.3, 8.3) 
Unskilled Workers/Farmers/ Soldiers 820 (41.6) 232 (28.3) 0.8 (0.6, 1.1) 0.9 (0.6, 1.2) 
Officers/Skilled Workers 887 (45.0) 252 (28.4) 0.8 (0.6, 1.1) 0.8 (0.6, 1.1) 
Professionals/Owners of Enterprise 259 (13.1) 84 (32.4) Ref Ref 
Residential Area 
    Suburban 590 (29.7) 182 (30.9) 1.1 (0.9, 1.4) 1.2 (0.9, 1.4) 
Urban 1398 (70.3) 392 (28.0) Ref Ref 
Para 
    Primipara 998 (50.2) 318 (31.9) 1.3 (1.1, 1.6) 1.0 (0.8, 1.3) 
Multipara 990 (49.8) 256 (25.9) Ref Ref 
N of ANC Visit 
    ≥4 times 1684 (84.7) 511 (30.3) 1.7 (1.2, 2.2) 1.7 (1.2, 2.3) 
<4 times 304 (15.3) 63 (20.7) Ref Ref 
Maternal BMI 
    Low 514 (25.9) 162 (31.5)  1.2 (1.0, 1.5) 1.1 (0.8, 1.3) 
Normal-High 1474 (74.1) 412 (28.0) Ref Ref 
Anemia 
    Yes 508 (25.6) 135 (26.6) 0.9 (0.7, 1.1) 0.9 (0.7, 1.1) 
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No 1480 (74.5) 439 (29.7) Ref Ref 
Mode of Delivery 
    Cesarean Section 830 (41.8) 233 (28.1) 0.9 (0.8, 1.1) 1.0 (0.8,1.2) 
Vaginal Delivery 1158 (58.3) 341 (29.5) Ref Ref 
Preterm Delivery 
    Yes 67 (3.4) 11 (16.4) 0.5 (0.2, 0.9) 0.5 (0.3, 1.1) 
No 1921 (96.6) 563 (29.3) Ref Ref 
【Neonates】 
LBW 
    Yes 45 (2.3) 9 (20) 0.6 (0.3, 1.3) 0.8 (0.3, 1.8) 
No 1943 (97.7) 565 (29.1) Ref Ref 
Light-for-Date 
    Yes 217 (10.9) 61 (28.1) 1.0 (0.7, 1.3) 1.0 (0.7, 1.4) 
No 1771 (89.1) 513 (29.0) Ref Ref 
Sex 
    Boys 1026 (51.6) 312 (30.4) 1.2 (1.0, 1.4) 1.2 (1.0, 1.4) 
Girls 962 (48.4) 262 (27.2) Ref Ref 
 
aItems with p-value <0.05 with statistical significance were underlined. 
bLogistic regression was used for univariate analysis for the indicated factors and for multivariate analysis, 
while chi’s square analysis was utilized for univariate analysis for the remaining factors.  
N, number; OR, odds ratio; CI, confidence interval; aOR, adjusted OR; ANC, antenatal care; BMI, body 





Table 2. Age-specific percentage of seronegative individuals, estimates of the CRS incidence per 100,000 
live births, and the number of CRS cases born in the year 2009 in Vietnam 
  Results of this study Estimates by modeling 
Age group      
(in years) 
All                  
N (%) 
IgG (-)             
N (%) (95%CI) 
CRS incidence per 
100,000 live births             
(95%CI) 
CRS cases in 2009 
in Vietnam       
N (95%CI) 
17-19 97 (4.9) 43 (44.3) (34.3, 54.4) 348 (308, 389)a 254 (225, 284)a 
20-24 475 (23.9) 170 (35.8) (31.5, 40.1) 285 (253, 319) 1091 (967, 1221) 
25-29 678 (34.1) 181 (26.7) (23.4, 30.0) 234 (208, 262) 1514 (1343, 1694) 
30-34 488 (24.5) 132 (27.0) (23.1, 31.0) 192 (170, 215) 599 (531, 670) 
35-39 207 (10.4) 44 (21.3) (15.6, 26.9) 158 (140, 177) 259 (188, 238) 
40-44 42 (2.1) 3 (7.1) (0.0, 15.3) 130 (115, 145) 71 (29, 36) 
45 1(0.1) 1 (100) (-) - - 
Total 1988 (100) 574 (28.9) (26.9, 30.9) 234 (207, 262)b 3788 (3283, 4143) 
 
aThe numbers in parentheses reflect 95% CI, based on profile likelihood. 
bCalculated as the average of the CRS incidence in five-year maternal age groups for 15-44 year olds, 
weighted by the number of live births in each age group. 





Figure 1. Frequency distribution of the ages of enrolled participants, Nha Trang, Vietnam, 2009-2010.  
The solid line shows the curve for the normal distribution.  
 
Figure 2. Comparison between predictions of the age-specific percentage individuals who were 
seronegative (solid line), obtained using the best-fitting catalytic model, and the observed data, Nha Trang, 
Vietnam, 2009-2010 (crosses, with 95% CI). 
 
Appendix 1. Birth weight percentiles of study participants by gestational week, Nha Trang, Vietnam, 
2009-2010. 
A diagram of birth weight percentiles by gestational week was created based on the data of subjects with a 
calculator proposed previously, assuming a mean birth weight at 40 weeks of 3379.6 g of and a standard 
deviation of 11.4% of the mean birth weight. Light-for-dates, defined as those below the 10th percentile of 
birth weight, were identified from this figure. 
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